Proceedings of the American Association for Cancer Research, Volume 43
Cancer Research, Incorporated, and American Association for Cancer Research, Incorporated, 2002 - Cancer
Contains abstracts of the scientific proceedings of the 73rd- annual meetings of the American Association for Cancer Research (1982- ).
74 pages matching treatment in this book
Results 1-3 of 74
What people are saying - Write a review
We haven't found any reviews in the usual places.
242 Osteopontin is a potential plasma marker for epithelial ovarian can abnormalities were detected in the only benign tumor tested Our findings indi...
from ovarian cancer cell lines and normal ovanan surface epithelial cells HOSE
231 Using amplified mRNA for measuring gene expression changes dur
2 other sections not shown
acid activity agents analysis androgen angiogenesis antibody antigen antitumor apoptosis assay binding BRCA1 breast cancer breast cancer cells cancer cell lines Cancer Center carcinogenesis carcinoma cells cDNA cell cycle cell growth cell lines cell proliferation cellular cisplatin clinical colon cancer colorectal compared correlation cyclin cytotoxic decreased demonstrated detected differentiation dose drug effect EGFR endothelial cells enzyme epithelial cells estrogen evaluated function gene expression growth factor HUVEC identified increased induced inhibition inhibitor invasion kinase levels LNCaP lung malignant mammary markers mediated melanoma metastasis metastatic mg/kg mice microarray molecular mouse mRNA mutations normal novel observed ovarian overexpression patients peptide phosphorylation plasma potential prodrug promoter prostate cancer protein rats receptor regulation response role RT-PCR samples sequence serum showed signaling pathways significant significantly specific staining suggest target therapeutic therapy tissue transcription factor transfected treatment tumor cells tumor growth University upregulated VEGF vitro vivo Western blot xenografts